Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK0893 in type 2 diabetes mellitus
NCT00479466Phase 2Terminated
- Sponsor
- Merck & Co.
- Start
- Jul 2007
- Primary completion
- May 2008
01
Overview
Phase 2, randomised, double-blind trial of MK-0893 in type 2 diabetes mellitus (T2DM), sponsored by Merck & Co. Started Jul 2007; status: terminated.
02
Drugs
MK-0893
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00479466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00479466.